Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-19-000492
Filing Date
2019-02-14
Accepted
2019-02-14 10:02:54
Documents
2
Group Members
D.N.A BIOMEDICAL SOLUTIONS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G zk1922679.htm SC 13G 90037
2 EXHIBIT 1 exhibit_1.htm EX-1 6923
  Complete submission text file 0001178913-19-000492.txt   98288
Mailing Address 6 URI STREET TEL AVIV L3 64954
Business Address
Bronfeld Zeev (Filed by) CIK: 0001298522 (see all company filings)

Type: SC 13G

Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Subject) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90847 | Film No.: 19601917
SIC: 2836 Biological Products, (No Diagnostic Substances)